Mutant epidermal growth factor receptor enhances induction of vascular endothelial growth factor by hypoxia and insulin-like growth factor-1 via a PI3 kinase dependent pathway
about
Type I insulin-like growth factor as a liver reserve assessment tool in hepatocellular carcinomaCoexpression of epidermal growth factor receptor with related factors is associated with a poor prognosis in non-small-cell lung cancer.A phase II study of capecitabine, oxaliplatin, bevacizumab and cetuximab in the treatment of metastatic colorectal cancer.Targeted Therapy: Can It Substitute for Chemotherapy?Quantitative proteomic analysis reveals effects of epidermal growth factor receptor (EGFR) on invasion-promoting proteins secreted by glioblastoma cells.Association of epidermal growth factor receptor mutations with metastatic presentations in non-small cell lung cancer.Erlotinib alone or with bevacizumab as first-line therapy in patients with advanced non-squamous non-small-cell lung cancer harboring EGFR mutations (JO25567): an open-label, randomized, multicenter, phase II studyHypoxia and the hypoxia-inducible-factor pathway in glioma growth and angiogenesis.Multi-Center Randomized Phase II Study Comparing Cediranib plus Gefitinib with Cediranib plus Placebo in Subjects with Recurrent/Progressive Glioblastoma.Breast tumour angiogenesisBlockade of glioma proliferation through allosteric inhibition of JAK2.EGFR wild-type amplification and activation promote invasion and development of glioblastoma independent of angiogenesisAntiangiogenic agents in first-line and second-line therapy for advanced colorectal cancer.First line targeted therapies in breast cancer: focus on bevacizumab.Role of bevacizumab therapy in the management of glioblastoma.EGFRvIII mutations can emerge as late and heterogenous events in glioblastoma development and promote angiogenesis through Src activation.The antiepidermal growth factor receptor monoclonal antibody cetuximab/C225 reduces hypoxia-inducible factor-1 alpha, leading to transcriptional inhibition of vascular endothelial growth factor expression.Uncovering the influence of the FGFR1 pathway on glioblastoma radiosensitivity.The Role of Hypoxia in Glioblastoma Invasion.
P2860
Q28080514-EB676691-E1DF-4A28-90D2-773DB19DF35DQ33206782-DB46AA23-B65D-4BE9-A97E-743CCA1C5F7AQ33931775-EEBF5187-6D54-4A0B-AE93-7B7106430B39Q34284290-6A946CA9-B861-4783-A3C6-80719E489B6BQ34303359-46F4EFCF-A59E-4518-9D49-F94366F30F9DQ35376683-7F63C1C0-483B-48B9-9EC2-0415D40C8C0BQ35790180-D49379C7-22F3-4218-9719-11149F0A478DQ35800467-4C4D0912-D20A-4355-82BD-40188A43CD9CQ36032533-4F9FB731-FE06-43F9-A4AE-85287F21468EQ36465291-A8761D88-6C3A-4E5D-AC23-D007828EE9B4Q36633592-59865639-58D3-43FF-8E0F-D64A2171F29EQ36780907-DF20D0EA-8B1A-4FD4-BA46-AA7ED57A26F3Q37153292-19FA1807-9986-42E8-8E6D-58FC4821C42BQ37290605-6C0304AC-7ADE-4715-946A-790D60A985A8Q37824254-5DAE1933-1433-457D-B5B3-E0FA20D2E819Q38765219-07253CC2-83AC-4D03-ABA4-EAB9AF2FC04FQ40439596-2807AA5A-8EBD-462F-93EC-1C633FCF299FQ42052965-860663F4-E14F-420A-8CBB-5943C9333EA4Q47374256-6CF695D5-3684-472B-9024-255DFF4EA178
P2860
Mutant epidermal growth factor receptor enhances induction of vascular endothelial growth factor by hypoxia and insulin-like growth factor-1 via a PI3 kinase dependent pathway
description
2001 nî lūn-bûn
@nan
2001 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2001 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2001年の論文
@ja
2001年論文
@yue
2001年論文
@zh-hant
2001年論文
@zh-hk
2001年論文
@zh-mo
2001年論文
@zh-tw
2001年论文
@wuu
name
Mutant epidermal growth factor ...... a PI3 kinase dependent pathway
@ast
Mutant epidermal growth factor ...... a PI3 kinase dependent pathway
@en
Mutant epidermal growth factor ...... a PI3 kinase dependent pathway
@nl
type
label
Mutant epidermal growth factor ...... a PI3 kinase dependent pathway
@ast
Mutant epidermal growth factor ...... a PI3 kinase dependent pathway
@en
Mutant epidermal growth factor ...... a PI3 kinase dependent pathway
@nl
prefLabel
Mutant epidermal growth factor ...... a PI3 kinase dependent pathway
@ast
Mutant epidermal growth factor ...... a PI3 kinase dependent pathway
@en
Mutant epidermal growth factor ...... a PI3 kinase dependent pathway
@nl
P2093
P2860
P921
P3181
P356
P1476
Mutant epidermal growth factor ...... a PI3 kinase dependent pathway
@en
P2093
P2860
P2888
P304
P3181
P356
10.1054/BJOC.2001.1805
P407
P577
2001-05-18T00:00:00Z
P5875
P6179
1052438642